ATC/DDD classification.
- Published in:
- 2015
- Publication type:
- Chart/Diagram/Graph
Works matching IS 10109609 AND DT 2015 AND VI 29 AND IP 4
Results: 46
1
2
EMA Article 58 positive opinion.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 468
- Publication type:
- Article
3
Publications and events.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 471
- Publication type:
- Article
4
WHO endorsements.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 469
- Publication type:
- Article
5
Extensions of indications.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 469
- Publication type:
- Article
6
ICH announces organizational changes.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 461
- Publication type:
- Article
7
Consultation documents.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 482
- Publication type:
- Article
8
EMA and WHO share non-public information.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 462
- Publication type:
- Article
9
Regulators of United Kingdom and India sign agreement.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 462
- Publication type:
- Article
10
Meeting of World Pharmacopoeias held in China.
- Published in:
- 2015
- Publication type:
- Proceeding
11
China and WHO collaborate on medicines quality.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 461
- Publication type:
- Article
12
Approved.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 463
- Publication type:
- Article
13
EMA initiative to improve patient registries.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 460
- Publication type:
- Article
14
New Zealand working on new regulatory regime.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 460
- Publication type:
- Article
15
Accelerated access pathways in Europe.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 460
- Publication type:
- Article
16
Falsified product alert.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 459
- Publication type:
- Article
17
Dibotermin alfa-containing implant kit: suspended in Europe.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 458
- Publication type:
- Article
18
Improved packaging for dementia treatments.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 458
- Publication type:
- Article
19
Human papillomavirus vaccines: benefits outweigh risks.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 456
- Publication type:
- Article
20
Safety reviews started.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 457
- Publication type:
- Article
21
HIV medicines: class warnings about lipodystrophy and lactic acidosis removed.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 457
- Publication type:
- Article
22
Entacapone: no clear evidence of cardiovascular events.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 457
- Publication type:
- Article
23
Apotex: Canada import ban lifted, product re-testing imposed.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 458
- Publication type:
- Article
24
Clopidogrel: no increased risk of death.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 456
- Publication type:
- Article
25
Dimethyl fumarate and other fumarate-containing medicines: new monitoring measures.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 456
- Publication type:
- Article
26
Clozapine: severe neutropenia.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 455
- Publication type:
- Article
27
Strontium: cardiovascular risks.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 455
- Publication type:
- Article
28
Roxithromycin: pseudo--membranous colitis, cardiac effects.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 455
- Publication type:
- Article
29
Ceftriaxone: acute generalised exanthematous pustulosis.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 455
- Publication type:
- Article
30
Mycophenolate: avoid exposure in pregnancy.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 454
- Publication type:
- Article
31
Canagliflozin: decreased bone mineral density.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 454
- Publication type:
- Article
32
Magnesium oxide: hypermagnesaemia in older patients.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 454
- Publication type:
- Article
33
Iodine-containing contrast agents: hypoactive thyroid in infants.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 453
- Publication type:
- Article
34
Sodium polystyrene sulfonate: separate dosing to prevent interactions.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 453
- Publication type:
- Article
35
Aripiprazole: impulse control disorders.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 453
- Publication type:
- Article
36
Fingolimod: skin cancer.
- Published in:
- 2015
- Publication type:
- Abstract
37
Crizotinib: heart failure.
- Published in:
- 2015
- Publication type:
- Abstract
38
Pharmacopoeial standards.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 440
- Publication type:
- Article
39
Vemurafenib: potentiation of radiation toxicity.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 452
- Publication type:
- Article
40
Antiviral combinations for hepatitis C: liver injury.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 451
- Publication type:
- Article
41
Mirabegron: contraindicated in patients with severe hypertension.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 451
- Publication type:
- Article
42
Quality of medicines.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 445
- Publication type:
- Article
43
Daclatasvir hydrochloride and asunaprevir: interstitial pneumonia.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 452
- Publication type:
- Article
44
Proposed International Nonproprietary Names: List 114.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 504
- Publication type:
- Article
45
Proton pump inhibitors: subacute cutaneous lupus erythematosus.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 451
- Publication type:
- Article
46
Cooperation.
- Published in:
- WHO Drug Information, 2015, v. 29, n. 4, p. 435
- Publication type:
- Article